by maheshbhuva | Jan 2, 2025 | Uncategorized
Share this: Click to share on Facebook (Opens in new window) Facebook Click to email a link to a friend (Opens in new window) Email Click to share on Reddit (Opens in new window) Reddit More Click to share on X (Opens in new window) X Click to share on LinkedIn (Opens...
by maheshbhuva | May 22, 2024 | Uncategorized
Reinventing Reputation: One of Pharma’s Biggest Challenges One of the biggest challenges for the pharmaceutical industry is reinventing its reputation. This task requires converting public perception from negative or skeptical to positive and trustworthy. Key...
by maheshbhuva | May 21, 2024 | Uncategorized
Sanofi and Regeneron’s Dupixent appears to be closing in on an FDA nod to expand its label to chronic obstructive pulmonary disorder (COPD). Data presented Monday at the American Thoracic Society (strengthen the company’s case for an approval....
by maheshbhuva | Nov 3, 2023 | 21 CFR, Uncategorized
21 CFR stands for Title 21 of the Code of Federal Regulations. It is a set of regulations issued by the United States Food and Drug Administration (FDA) that covers various aspects of regulatory requirements for pharmaceuticals, medical devices, food, cosmetics, and...
by maheshbhuva | Dec 18, 2022 | Uncategorized
ALCOA to ALCOA Plus for Data Integrity : Pharmaceutical Guidelines ALCOA to ALCOA Plus for Data Integrity ALCOA was an tool to implement the data integrity in pharmaceutical manufacturing facility but ACLOA + made this tool more powerful and sharp. Data security has...
by maheshbhuva | Dec 18, 2022 | Uncategorized
potentiometery titration Share this: Click to share on Facebook (Opens in new window) Facebook Click to email a link to a friend (Opens in new window) Email Click to share on Reddit (Opens in new window) Reddit More Click to share on X (Opens in new window) X Click to...
